Inhibitory Effects of Polygonum cuspidatum on the Epstein-Barr Virus Lytic Cycle

被引:0
|
作者
Yiu, Ching-Yi [2 ]
Chen, Shih-Ying [3 ]
Huang, Ching-Wen [4 ]
Yeh, Dong-Bor [4 ]
Lin, Tsuey-Pin [1 ]
机构
[1] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan
[2] Chi Mei Med Ctr, Dept Otolaryngol, Tainan, Taiwan
[3] Chia Nan Univ Pharm & Sci, Dept Appl Life Sci & Hlth, Tainan, Taiwan
[4] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan
关键词
Polygonum cuspidatum; antiviral activity; EBV; LYMPHOBLASTOID CELL-LINES; RESVERATROL INHIBITION; GROWTH-FACTOR; REPLICATION; TRANSCRIPTION; ACTIVATION; INFECTION; MACROPHAGES; NUCLEOSIDE; BUTYRATE;
D O I
暂无
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Polygonum cuspidatum is widely used as a medicinal herb in Asia. In this study, we examined the ethanolic extract of Polygonum cuspidatum roots (PcE) for their capacity to inhibit the EBV lytic cycle. The cell viability was determined by the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] method. The expression of Epstein-Barr virus (EBV) lytic proteins was analyzed by flow cytometric assay. Real-time quantitative PCR was used to measure the EBV virion production. Transient transfection analysis was subsequently performed to assess the transcription of lytic genes, including BRLF1 and BZLF1. Results showed that the PcE inhibited the transcription of EBV immediate early genes, the expression of EBV lytic proteins, including Rta, Zta, and EA-D and reduced the production of virus particles, showing that PcE is useful for preventing the proliferation of the virus.
引用
收藏
页码:107 / 113
页数:7
相关论文
共 50 条
  • [31] Analysis of Epstein-Barr virus and cellular gene expression during the early phases of Epstein-Barr virus lytic induction
    Auburn, Helen
    Zuckerman, Mark
    Smith, Melvyn
    JOURNAL OF MEDICAL MICROBIOLOGY, 2016, 65 : 1243 - 1252
  • [32] Epstein-Barr virus lytic infection in lymphocytes and the persistence of the virus - Response
    Schwarzmann, F
    BLOOD, 1997, 90 (05) : 2115 - 2116
  • [33] A cosmid system for the analysis of lytic replication of Epstein-Barr virus
    Hung, CH
    Kwang, MJ
    Liu, ST
    ANALYTICAL BIOCHEMISTRY, 1999, 273 (02) : 315 - 318
  • [34] Functional Implications of Epstein-Barr Virus Lytic Genes in Carcinogenesis
    Yap, Lee Fah
    Wong, Anna Kang Chee
    Paterson, Ian C.
    Young, Lawrence S.
    CANCERS, 2022, 14 (23)
  • [35] Inhibitory effects of lantadenes and related triterpenoids on Epstein-Barr virus activation
    Inada, A
    Nakanishi, T
    Tokuda, H
    Nishina, H
    Iwashima, A
    Sharma, OP
    PLANTA MEDICA, 1995, 61 (06) : 558 - 559
  • [36] A cosmid system for the analysis of lytic replication of Epstein-Barr virus
    Hung, CH
    Kwan, MJ
    Liu, ST
    ANALYTICAL BIOCHEMISTRY, 1999, 272 (02) : 277 - 280
  • [37] The role of microRNAs in Epstein-Barr virus latency and lytic reactivation
    Forte, Eleonora
    Luftig, Micah A.
    MICROBES AND INFECTION, 2011, 13 (14-15) : 1156 - 1167
  • [38] Regulation of the latent-lytic switch in Epstein-Barr virus
    Kenney, Shannon C.
    Mertz, Janet E.
    SEMINARS IN CANCER BIOLOGY, 2014, 26 : 60 - 68
  • [39] Presence of lytic Epstein-Barr virus infection in nasopharyngeal carcinoma
    Yu, Fenggang
    Lu, Yanan
    Petersson, Fredrik
    Wang, De-Yun
    Loh, Kwok Seng
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (07): : 1515 - 1523
  • [40] Cordycepin enhances Epstein-Barr virus lytic infection and Epstein-Barr virus-positive tumor treatment efficacy by doxorubicin
    Du, Yinping
    Yu, Jieshi
    Du, Li
    Tang, Jun
    Feng, Wen-Hai
    CANCER LETTERS, 2016, 376 (02) : 240 - 248